Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenic appearance of BDNF in the striatum

Journal of Neuroscience

Volumn 18, Issue 15, 1998, Pages 6040-6047

  Yurek, David M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Brain derived neurotrophic factor; Development; Dopamine; Fiber outgrowth; Neural transplantation; Neurotrophic factor; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; NEUROTROPHIC FACTOR; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; FETAL TISSUE TRANSPLANTATION; INTRACEREBRAL DRUG ADMINISTRATION; NEOSTRIATUM; NERVE FIBER GROWTH; NONHUMAN; ONTOGENY; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RAT; SUBSTANTIA NIGRA;

EID: 0032146098     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-15-06040.1998     Document Type: Article

References (6)

1. Altar CA, Wiegand SJ, Lindsay RM, Cedarbaum JM (1996) Neurotrophic factors: towards a restorative therapy of Parkinson's disease. In: Neuroprotective approaches to the treatment of neurodegenerative disease (Olanow CW, Jenner P, Youdim M, eds), pp 160-180. London: Academic.
2. Altar CA, Cai N, Bliven T, Juhasz M, Connor JR, Acheson A, Lindsay RM, Wiegand SJ (1997) Anterograde transport of BDNF and its role in the brain. Nature 389:856-860.
3. Coyle JT, Campochiaro P (1976) Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: a neurochemical study. J Neurochem 27:673-678.
4. Ebendal T (1992) Function and evolution in the NGF family and its receptors. J Neurosci Res 32:461-470.
5. Engele J, Bonn MC (1991) The neurotrophic effects of basic fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J Neurosci 11:3070-3078.
6. Gall CM, Gold SJ, Isackson PJ, Seroogy KB (1992) Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol Cell Neurosci 3:56-63.